Bill Zarkalis, Titan America CEO, joins 'The Exchange' to discuss the company's debut on the New York Stock Exchange.
Shares of Titan America rose 1.25% in their debut on the New York Stock Exchange, giving the Belgium-based cement producer a ...
Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a ...
Titan America SA (“Titan America”), a subsidiary of Titan Cement International SA and parent company of its U.S. operations, ...
Titan America's initial public offering was priced toward the low end of expectations, giving the U.S. arm of Belgian cement producer Titan Cement International an initial market value of about $2.95 ...
Shares of Titan America rose 1.25% in their debut on the New York Stock Exchange, giving the Belgium-based cement producer a ...
Titan America expects to receive net proceeds of approximately 136,800,000 dollars, after deducting underwriting discounts and commissions ...
Titan America SA ("Titan America"), a subsidiary of Titan Cement International SA and parent company of its U.S. operations, ...
Titan America SA TTAM IPO will take place February, 07 on the NYSE exchange under the ticker TTAM. The company is offering shares at an expected price between $15.00 and $18.00 per share with an ...